07:00 , Apr 29, 2013 |  BC Week In Review  |  Clinical News

Anti-CCP IVD kit regulatory update

Theradiag said it received CE Mark approval for its anti- cyclic citrullinated peptide (anti-CCP) antibodies in vitro diagnostic (IVD) kit to detect rheumatoid arthritis (RA). The company said the kit will be available worldwide. Theradiag...